Context Therapeutics Inc. (CNTX) Tops Q1 EPS by 7c

Context Therapeutics Inc. (NASDAQ: CNTX) reported Q1 EPS of ($0.05), $0.07 better than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Context Therapeutics Inc. (CNTX) click here.

You May Also Be Interested In

• Goldman Equities Haul To Rip Past $5 Billion Toward New Record - Bloomberg
• Allegiant Travel Company (ALGT) PT Raised to $103 at UBS
• Nvidia launches BioNeMo Agent Toolkit for life sciences AI agents